![]() |
市场调查报告书
商品编码
1847206
欧洲的牙科用植入市场:市场规模,占有率,趋势分析(2025年~2031年)Dental Implants Market Size, Share & Trends Analysis | Europe | 2025-2031 | Includes: Dental Implants, Final Abutments, Instrument Kits, and 2 more |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024年,欧洲牙科植体和最终基台市场规模超过13亿欧元,预计到2031年将达到近19亿欧元,预测期内复合年增长率(CAGR)为4.8%。
本报告涵盖牙科植体、最终基台、治疗计画软体和手术导板。牙科植体按高端、经济型、折扣型和迷你型进行细分,并按材料分为钛和陶瓷/氧化锆。最终基台按製造方式(现货、客製化铸造、CAD/CAM)和材料(钛、陶瓷/氧化锆、黄金)进行细分。治疗计划软体分析包括新安装费用和服务/维护费用,手术导板按製造商(传统製造商、第三方製造商、内部製造商)进行细分。
本报告量化了单位销售、平均售价 (ASP)、市场价值、成长率和公司占有率。报告还评估了市场推动因素和阻碍因素、技术和工作流程趋势以及近期併购活动。历史资料截至 2021 年,预测资料截至 2031 年。报告的结构和流程与 iData 的输液治疗设备参考手册格式一致,确保经销商页面的一致性。
市场概览
欧洲植体和基台市场正稳步从传统的类比工作流程向数位化牙科转型,将诊断、计划、植入和修復环节连接起来。基于 CBCT 的计划、导板手术和 CAD/CAM 基台的应用提高了治疗精度并缩短了就诊时间。这增强了新晋临床医生的信心,并提高了全科诊所对此类病例的接受度。
由于患者寻求美观耐用且能与天然牙齿融合的解决方案,单颗牙齿修復的需求增长速度超过了义齿固位的需求。高端种植系统凭藉其悠久的临床历史、全面的组件库和强大的服务网络,在复杂且注重美观的病例中保持优势。同时,经济型和折扣型品牌正在常规适应症、联合诊所和价格敏感型市场中占越来越大的占有率,这给多个国家的平均销售价格(ASP)带来了下行压力。
随着技工室和椅旁系统简化扫描提交和设计审核流程,最终基台领域正朝着CAD/CAM方向发展。开放式架构的工作流程允许来自不同扫描器和设计工具的数位檔案导入相容的加工系统,从而扩大了CAD/CAM基台的应用范围。这一趋势提高了灵活性,减少了返工,并确保了品质的一致性。
治疗计画软体部门从定期维护和续订费用中获利。随着安装量的成长,庞大的用户群支撑着稳定的服务收入。随着诊所和实验室数位化能力的提升,手术导板正逐渐从诊所内部製造商转向第三方製造商,但对于复杂的多单元和全口种植病例,製造商生产的导板仍然是主流选择。
义大利、瑞士、斯堪的纳维亚半岛和比荷卢经济联盟的植牙普及率已经很高。法国和英国的植牙普及率较低,但仍有成长空间,而宣传活动、融资方案和数位化工作流程正在推动植牙的普及。宏观经济因素和家庭信心将继续影响病例组合和治疗时机,尤其是在选择性美学治疗方面。
市场推动因素
对较佳美观效果的需求
欧洲患者仍偏好牙色、外观自然的修復体,这些修復体既能保持功能,又能维护长期的口腔健康。与牙桥相比,植牙的优点在于无需磨除邻牙,并能保留齿槽骨。因此,单颗植牙修復体是成长最快的细分市场。即使在整体经济状况疲软的情况下,病患教育、大众对植牙的接受度以及诊所的融资方案也能确保病例数的稳定。
数位化牙科
数位化工具的快速成熟正在推动植牙置换率的提高。锥状束CT (CBCT) 可以精确地以三维形式呈现骨量和解剖结构,从而改善治疗计划和风险评估。导板手术软体可以将这些治疗计划转化为精确的手术导板。 CAD/CAM 解决方案可以创建患者客製化的基台,从而优化牙龈轮廓和软组织支撑。製造商正在投资教育中心和区域创新中心,以扩大数位化应用并缩短学习曲线。这些投资提高了护理标准,提高了病例接受度,并将客户锁定在整合的软硬体生态系统中。
改进的兼容性和开放的工作流程
供应商正在开放其系统,以接受来自更多设备和平台的扫描和 CAD 檔案。例如,植体规划套件与主流口内扫描器的兼容性,使临床医生无需改造现有设备即可提交病例。开放式架构减少了摩擦,扩大了CAD/CAM基台的取得途径,并支援互补产品的交叉推广。这使得库存和客製化基台的订单流程更加顺畅,并增强了相关植体、器械和修復组件的销售。
市场限制因子
可支配所得与消费者信心
植牙通常是一种选择性消费。当消费者信心下降时,患者会延后单颗牙齿修復或选择成本较低的替代方案。这种趋势因国家而异,自付费用和私人保险会影响需求。虽然诊所正在透过分阶段治疗计划和融资来应对,但宏观经济压力仍可能推迟高端产品组合和全口种植病例的出现。
经济型和折扣型植体的日益普及
经济型和折扣型品牌凭藉可靠的核心性能和更低的价格,持续扩大市场占有率。这种转变压缩了品类层面的平均售价。为了保持竞争力,即使是高端品牌也在透过选择性折扣、产品组合捆绑和教育项目来捍卫其市场占有率。在常规适应症和价格敏感型市场,这种压力最为显着,因为高端产品和经济型产品之间的认知差距正在缩小。
成熟国家的高市场渗透率
成熟的植体市场已经拥有很高的渗透率。进一步成长取决于从竞争对手手中夺取市场占有率、将适应症扩展到更年轻的人群以及将传统诊所升级为数位化工作流程。法国和英国等植体渗透率历来较低的国家正在提供更多治疗选择,但成长仍取决于临床医生的培训、患者的融资以及能够降低风险的可预测治疗结果。
对象市场与资料范围
定量的范围
市场规模,市场占有率,市场预测,成长率,销售台数,平均销售价格。
定性的范围
成长趋势,阻碍因素,竞争分析及竞争前几名企业的SWOT,M&A,企业简介及产品系列,FDA回收,颠覆性技术,输液疗法的需求形成的疾病概要。
期间
基准年(2024年),预测(2025年~2031年),过去资料(2021年~2023年)
资料来源
对产业领导者的1次采访,政府医生资料,法规资料,医院私人资料,进出口资料,iData Research公司内部资料库。
市场区隔
人工植牙
最终基台
器械包
治疗计划软体
分析中,包含新安装,更新,支援,整合相关的服务/维修费。
手术模板
竞争分析
士卓曼集团将在2024年占欧洲市场最大的市场占有率。其领先地位源于其在植牙和最终基台领域的强大实力,以及在治疗计划软体和手术导板领域的显着影响力。本公司提供涵盖钛基和陶瓷植体的各种价格区间的产品,包括高端、经济型(包括Neodent)和折扣产品。士卓曼的产品组合涵盖全口修復、CAD/CAM基台和再生生物材料,增强了客户黏性。持续投资于数位化工作流程和教育,使其保持了先发优势。
登士柏西诺德凭藉其在治疗计划软体和手术导板领域的领先地位以及丰富的植体产品组合,在市场占有率方面位居第二。其SIMPLANT®和SICAT®软体的深度积累,使其在计划、资料管理和导板製造方面拥有强大的实力。 CAD/CAM解决方案以及与第三方扫描器不断扩展的兼容性,支援高效的修復工作流程,从而推动了对基台和植体的需求。
Envista透过其子公司Nobel Biocare和Implant Direct位居第三。 Nobel Biocare是All-on-4®数位化工作流程的先驱,也是一家主要的高端企业,提供整合植体、基台和相关组件的综合系统。 Envista透过覆盖高端和经济型市场,吸引了广泛的客户群。
持续的技术创新推动持续成长。
其他进入者服务全国性和细分市场。本地领导者在价值和折扣市场竞争,通常利用强大的经销商关係和有吸引力的定价策略。专注于高端市场的中型企业利用陶瓷植体和先进的基台材料,满足美观和复杂的适应症需求。
技术与实务趋势
端到端的数位化工作流程结合了锥形束CT (CBCT)、口内扫描、规划软体、导板手术和CAD/CAM基台,以提高精度并缩短椅旁操作时间。
开放式架构相容性。更广泛的文件接受度和扫描器互通性简化了病例提交,减少了返工,并支持CAD/CAM基台的稳定成长。
陶瓷/氧化锆的扩张。由于美观且不含金属,陶瓷植体和氧化锆基台在前牙区越来越受欢迎,但钛仍然是大多数适应症的标准选择。
全口和即刻修復方案。标准化组件和规划工具支援符合骨质和稳定性标准的全口治疗和即时负重。
教育和中心。供应商正在投资培训中心和数位化实验室,以缩短学习曲线并促进一致的临床结果。
分散式导板製造。随着实验室和诊所开发列印和验证能力,内部和第三方导板製造将会扩大,而製造商将在复杂病例中保持市场占有率。
区域
本期重点在于欧盟 (EU)。
包含方法附录和缩写。
到 2031 年,欧洲植体、基台、软体和导板领域中规模最大、成长最快的机会在哪里?
价值型和折扣型产品的市占率成长速度及其对平均售价和产品组合的影响。
哪些数位化工具对日常诊疗中的个案接受率、准确率和返工率影响最大?
开放式工作流程和扫描器相容性将如何影响 CAD/CAM 基台的需求和技工室的运作?
美学区陶瓷/氧化锆植体和基台的前景如何?
宏观经济的不确定性将如何影响择期治疗的时机、病患的融资、全口种植个案的规划?
iData Research 的 "欧洲牙科植体和最终基台市场报告" 透过基于流程的模型、公司占有率分析和定价详情,解答了这些问题。
利用该报告量化需求、确定产品路线图的优先顺序、协调培训和教育,并优化欧洲高端、价值和折扣细分市场的商业策略。
图表一览
表(图表)一览
欧洲的人工植牙及最终基台市场概要
竞争分析
市场趋势
市场趋势
终端用户分析
市场区隔
主要的报告的更新
版本履历
调查手法
全球关税的影响
欧洲的人工植牙及最终基台市场概要
国家概况
终端用户分析
人工植牙市场
最终基台市场
治疗计划软体市场
手术指南市场
The European market for dental implants and final abutments was valued at over €1.3 billion in 2024. The market is expected to increase at a CAGR of 4.8% over the forecast period to reach nearly €1.9 billion by 2031.
This report covers dental implants, final abutments, treatment planning software, and surgical guides. Dental implants are segmented into premium, value, discount, and mini categories and also by material as titanium and ceramic/zirconia. Final abutments are segmented by fabrication (stock, custom cast, CAD/CAM) and by material (titanium, ceramic/zirconia, gold). Treatment planning software analysis includes new installations and service/maintenance fees, while surgical guides are segmented by manufacturing source (traditional manufacturer, third party, in-house).
The report quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares. It evaluates market drivers and limiters, technology and workflow trends, and recent mergers and acquisitions. Historical data are provided to 2021 with forecasts through 2031. The structure and flow mirror the format used in iData's infusion therapy device reference to aid consistency across reseller pages.
Market Overview
Europe's implant and abutment market reflects a steady shift from traditional analog workflows to digital dentistry that links diagnostics, planning, placement, and restoration. Adoption of CBCT-based planning, guided surgery, and CAD/CAM abutments is improving treatment accuracy and shortening chair time. This is increasing confidence among newer clinicians and raising case acceptance rates in general practice settings.
Demand for single-tooth replacement is expanding faster than denture retention, as patients seek aesthetic and durable solutions that integrate with natural dentition. Premium implant systems maintain an edge in complex and esthetic cases due to long clinical histories, comprehensive component libraries, and robust service networks. At the same time, value and discount brands are winning share in routine indications, group practices, and price-sensitive markets, which places downward pressure on ASPs in several countries.
The final abutment segment is moving toward CAD/CAM as labs and chairside systems streamline scan submission and design approvals. Open-architecture workflows are widening access to CAD/CAM abutments by allowing digital files from different scanners and design tools to flow into compatible production systems. This trend improves flexibility, reduces remakes, and supports consistent quality.
The treatment planning software segment benefits from recurring maintenance and update fees. As installations grow, the installed base supports stable service revenue. Surgical guides are shifting toward in-house and third-party fabrication as clinics and labs build digital capacity, though manufacturer-produced guides remain prevalent for complex multi-unit and full-arch cases.
Overall, unit growth is positive across Europe, with penetration already high in Italy, Switzerland, Scandinavia, and the Benelux region. Growth headroom remains in France and the U.K., where implant penetration is lower and awareness campaigns, financing options, and digital workflows can lift adoption. Macroeconomic factors and household confidence still influence case mix and timing, particularly for elective esthetic treatments.
Market Drivers
Demand for Improved Aesthetics
European patients continue to prefer tooth-colored, natural-looking restorations that preserve function and support long-term oral health. Implants offer advantages over bridges by avoiding preparation of adjacent teeth and by preserving bone. As a result, single-tooth replacement is the fastest growing application. Wider patient education, social acceptance of implants, and financing options from clinics support steady case volumes even when general economic sentiment softens.
Digital Dentistry
The rapid maturation of digital tools is raising the implant replacement rate. CBCT enables accurate 3D visualization of bone volume and anatomy, which improves treatment planning and risk assessment. Guided surgery software converts these plans into precise surgical guides. CAD/CAM solutions produce patient-specific abutments that optimize emergence profile and soft tissue support. Manufacturers are investing in education hubs and regional innovation centers to expand digital adoption and shorten learning curves. These investments raise the standard of care, support higher case acceptance, and anchor customers within integrated software-hardware ecosystems.
Increased Compatibility and Open Workflows
Vendors are opening their systems to accept scans and CAD files from a broader set of devices and platforms. For example, compatibility between implant planning suites and leading intraoral scanners allows clinicians to submit cases without changing existing equipment. Open architecture reduces friction, expands access to CAD/CAM abutments, and supports cross-promotion of complementary products. The result is a smoother order flow for stock and custom abutments and stronger pull-through for associated implants, instruments, and restorative components.
Market Limiters
Disposable Income and Consumer Confidence
Implant dentistry is often an elective purchase. When consumer confidence weakens, patients may delay single-tooth replacement or choose lower-cost alternatives. This dynamic varies by country, with out-of-pocket exposure and private insurance coverage shaping demand. Clinics respond with staged treatment plans and financing, but macroeconomic pressure can still slow premium mix and full-arch cases.
Growing Popularity of Value and Discount Implants
Value and discount brands continue to gain share by offering reliable core performance at lower prices. This shift compresses ASPs at the category level. To stay competitive, even premium brands use selective discounting, portfolio bundling, and education programs to defend share. Pressure is strongest in routine indications and price-sensitive markets where the perceived gap between premium and value outcomes is narrower.
High Market Penetration in Mature Countries
In long-established implant markets, penetration is already high. Incremental growth depends on winning share from competitors, expanding indications to younger cohorts, and upgrading analog clinics to digital workflows. Countries with lower historical penetration, such as France and the U.K., offer more runway, but growth still relies on clinician training, patient financing, and predictable outcomes that reduce perceived risk.
Market Coverage and Data Scope
Quantitative coverage
Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
Qualitative coverage
Growth trends, limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls, disruptive technologies, and disease overviews that shape demand for infusion therapy.
Time frame
Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2023.
Data sources
Primary interviews with industry leaders, government physician data, regulatory data, hospital private data, import and export data, and the iData Research internal database.
Market Segmentation
Dental Implants
Final Abutments
Instrument Kit
Treatment Planning Software
Analysis includes new installations and service/maintenance fees tied to updates, support, and integration.
Surgical Guides
Competitive Analysis
Straumann Group held the largest share of the total European market in 2024. Leadership stems from strong positions in dental implants and final abutments, with meaningful presence in treatment planning software and surgical guides. The company addresses all price tiers through premium, value (including Neodent), and discount offerings, and spans titanium and ceramic implants. Straumann's portfolio integrates full-arch restorations, CAD/CAM abutments, and regenerative biomaterials, which strengthens account stickiness. Continuous investment in digital workflows and education sustains its first-mover advantage.
Dentsply Sirona held the second-largest share, driven by leadership in treatment planning software and surgical guides and by a broad implant portfolio. The company's software heritage through SIMPLANT(R) and SICAT(R) underpins strong positions in planning, data management, and guide production. Its CAD/CAM solutions and expanding compatibility with third-party scanners support efficient restorative workflows and help pull through abutment and implant demand.
Envista ranked third through its subsidiaries Nobel Biocare and Implant Direct. Nobel Biocare pioneered the All-on-4(R) digital workflow and remains a key premium player with comprehensive systems that include implants, abutments, and related components in integrated packages. Envista's coverage of premium and value tiers supports broad customer reach, while continued innovation under Nobel Biocare positions the group for ongoing growth.
Other participants serve national and niche segments. Local champions compete in value and discount tiers, often with strong distributor relationships and attractive price points. Premium-focused midsize firms address esthetic and complex indications with ceramic implants and advanced abutment materials.
Technology and Practice Trends
End-to-end digital workflow. Clinics combine CBCT, intraoral scanning, planning software, guided surgery, and CAD/CAM abutments to improve accuracy and cut chair time.
Open architecture compatibility. Broader file acceptance and scanner interoperability simplify case submission and reduce remakes, supporting steady CAD/CAM abutment growth.
Ceramic/zirconia expansion. Ceramic implants and zirconia abutments gain attention for esthetics in the anterior zone and for metal-free preferences, though titanium remains the standard for most indications.
Full-arch and immediate protocols. Standardized components and planning tools support full-arch treatments and immediate loading where bone quality and stability criteria are met.
Education and hubs. Vendors invest in training centers and digital labs to shorten learning curves and promote consistent clinical outcomes.
Distributed guide manufacturing. In-house and third-party guide production expands as labs and clinics develop printing and validation capabilities, while manufacturers retain share in complex cases.
Geography
This edition covers the European Union.
Methodology Appendix and Acronym Glossary included.
Where are the largest and fastest-growing opportunities within Europe's implant, abutment, software, and guide categories through 2031.
How fast are value and discount segments gaining share and what are the implications for ASPs and mix.
Which digital tools most influence case acceptance, accuracy, and rework rates in daily practice.
How do open workflows and scanner compatibility shape CAD/CAM abutment demand and lab operations.
What is the outlook for ceramic/zirconia implants and abutments in esthetic zones.
How does macroeconomic uncertainty affect elective treatment timing, patient financing, and full-arch case pipelines.
The European Dental Implant and Final Abutment Market Report from iData Research answers these questions with procedure-aware models, company share analysis, and pricing detail.
Use it to quantify demand, prioritize product roadmaps, align training and education, and optimize commercial strategies for premium, value, and discount segments across Europe.
Table Of Contents
List Of Figures
List Of Charts
European Dental Implant And Final Abutment Market Overview
Competitive Analysis
Market Developments
Market Trends
End-User Analysis
Market Segmentation
Key Report Updates
Version History
Research Methodology
Impact Of Global Tariffs
European Dental Implant And Final Abutment Market Overview
Country Profiles
End-User Analysis
Dental Implant Market
Final Abutment Market
Treatment Planning Software Market
Surgical Guide Market